Navigation Links
JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS
Date:8/6/2013

ef="http://www.jazzpharmaceuticals.com/">www.jazzpharmaceuticals.com.

Non-GAAP Financial MeasuresTo supplement Jazz Pharmaceuticals' financial results and guidance presented on a GAAP basis, the company uses certain non-GAAP adjusted financial measures.  The company believes that these non-GAAP financial measures are helpful in understanding its past financial performance and potential future results, particularly in light of the effect of various acquisition and divestiture transactions effected by the company during 2012.  They are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with the consolidated financial statements prepared in accordance with GAAP.  Jazz Pharmaceuticals' management regularly uses these supplemental non-GAAP financial measures internally to understand, manage and evaluate its business and make operating decisions.  Compensation of executives is based in part on the performance of the company's business based on certain of these non-GAAP measures.  In addition, Jazz Pharmaceuticals believes that the use of these non-GAAP measures enhances the ability of investors to compare its results from period to period.  The non-GAAP adjusted financial measures as used by Jazz Pharmaceuticals in this press release may be calculated differently from, and therefore may not be directly comparable to, similarly titled measures used by the company's competitors and other companies.

As used in this press release, (i) the historical adjusted net income measures exclude from GAAP income from continuing operations, as applicable, amortization of intangible assets, share-based compensation expense, acquisition accounting inventory fair value step-up adjustments, transaction and integration costs, restructuring charges, change in fair value of contingent consideration, upfront license fees, depreciation expense, loss on
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Cumberland Pharmaceuticals Reports Second Quarter Financial Results
2. Inovio Pharmaceuticals Responds to Market Activity
3. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
4. Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
5. Avanir Pharmaceuticals to Participate in Two Conferences in August
6. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
7. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
8. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
9. Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference
10. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
11. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ... second quarter 2015 financial results on Monday, August 10, ... markets. The Company will host a conference call and ... Eastern Time on August 10, 2015. The ... the Investor Relations section of the Company,s Web site ...
(Date:7/6/2015)... HORSHAM, Pa. , July 6, 2015 /PRNewswire/ ... procedure-based, bone fixation concept the FlowerCube™, announced today ... approval opens the opportunity for significant expansion of ...   The approval encompasses Flower Orthopedics, ... fixation solutions for upper and lower extremities. Consisting ...
(Date:7/6/2015)... NEWTOWN, Pa. , July 6, 2015 /PRNewswire/ ... services and technology provider, today announced that it ... retention firm, MediciGroup ® , Inc. (Medici).  The ... Access to Patients, LLC.  Medici also provides a ... finds missing patients globally.  Together with Medici, ...
Breaking Medicine Technology:Impax to Report Second Quarter 2015 Results on August 10, 2015 2Flower Orthopedics cleared to enter the European Union 2BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3
... presented this week at the International Federation of Clinical ... lower diagnostic threshold for troponin improves clinical outcomes and ...  Troponin is a protein found inside of heart cells ... or reduced blood supply.   Cardiac troponin ...
... Neuro Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), ... for neuro-physiologic, neuro-otologic, vestibular and neurological testing, said ... its VEST™ control and analysis software. ... software to conduct vestibular, oculomotor and optokinetic tests ...
Cached Medicine Technology:Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 2Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 3Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 4Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software 2
(Date:7/7/2015)... ... July 07, 2015 , ... ... strong managerial expertise to oversee large healthcare operations and their success is ... partners, insurance companies, and regulators. American Sentinel University, an innovative, accredited provider ...
(Date:7/7/2015)... ... July 07, 2015 , ... On May 29, 2015, Health Canada ... the use of gluten-free claims for gluten free oats and foods that contain them ... Gluten-Free Certification Program (GFCP) to include gluten-free oat products in Canada,” says Frank ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... today announced they have been selected by the Department of Vermont Health Access ... its Medicaid Management Information System (MMIS) and Integrated Contact Center System project. , ...
(Date:7/6/2015)... ... July 06, 2015 , ... Human induced pluripotent ... iPSCs are generated from adult cells, such as blood or skin, can replicate ... human body. , iPSC-derived cardiomyocytes have proven valuable in helping ...
(Date:7/6/2015)... ... July 06, 2015 , ... University of Pittsburgh Cancer Institute ... thyroid cancer testing to reflect newly available tests that better incorporate personalized medicine into ... to interpret thyroid cancer tests is published in the July issue of the scientific ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5
... leads (Medtronic) failed more often in younger patients, women, ... multicenter study published online Jan. 17 in Circulation ... associated with death or serious injuries. ... experienced painful inappropriate shocks, according to lead author Robert ...
... of the E2F transcription factor family, and plays a key ... been reported in various human cancers, but not in liver ... not known whether E2F5 plays a tumor suppressor role or ... the expression profile of E2F5 in HCC and its biological ...
... life be easy if everything happened as we anticipated? In ... using an inbuilt network that makes predictions about the world ... the front of the brain, called the orbitofrontal cortex, plays ... damage to this area confuse memories with reality and continue ...
... in the journal Clinical Cardiology reveals that a Super ... rates in both men and women and in older individuals. , ... When the team loses, it can cause some degree of emotional ... Heart Institute, Good Samarian Hospital and Keck School of Medicine at ...
... Dennis Thompson HealthDay Reporter , FRIDAY, Jan. ... concerns over a decision by a drug manufacturer to ... of the medication,s use in lethal injections in prison ... to produce Pentothal (sodium thiopental) at its plant in ...
... HOUSTON - Practicing stress management techniques before prostate cancer ... to quicker recovery, as well as aid in lowering ... at The University of Texas MD Anderson Cancer Center. ... edition of the journal Psychosomatic Medicine . It,s ...
Cached Medicine News:Health News:Recalled ICD leads fail in women, youths most often 2Health News:Revealing the wiring that allows us to adapt to the unexpected 2Health News:Will Loss of Lethal Injection Drug Harm Surgical Patients? 2Health News:Will Loss of Lethal Injection Drug Harm Surgical Patients? 3Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 2Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 3
VG1 ALIF (Anterior Lateral) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts...
Medicine Products: